Identifying and quantifying peptides is key to characterizing and monitoring the quality of biopharmaceuticals. Genedata Expressionist® provides out-of-the-box capabilities for the efficient detection and quantitation of posttranslational modifications (including unexpected wildcard modifications), sequence variants, and glycosylated peptides.
The platform’s open architecture enables you to import data from any search engine or library. Results from different datasets can be combined to give a complete overview across multiple samples. The flexible workflow-based data-processing pipelines enable innovative data-processing strategies that significantly reduce false-positive identifications, typically reducing manual validation efforts from weeks to hours.
Request the Sanofi Case Study